During the Fall and before summer starts, dermatologists recommended for an annual skin exam, email your appointment request here. With our revolutionary iPad system; we are able to focus on head-to-toe screenings and early detection.
FDA fast tracks the development of Cemiplimag, treating adults with metastatic cutaneous squamous cell carcinoma (CSCC). CSCC is the second most common type of skin cancer in the United States, learn more here, Dermatology News.
This website includes materials that are protected by copyright, or other proprietary rights. Transmission or reproduction of protected items beyond that allowed by fair use, as defined in the copyright laws, requires the written permission of the copyright owners.